Results 51 to 60 of about 1,034,274 (259)

Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry [PDF]

, 2023
BACKGROUND Within the spectrum of spondyloarthritides, axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) present with overlapping features. Axial involvement in PsA (axial PsA) is treated according to recommendations for axSpA, as specific
Bernatschek, Alexander, Burkhard Möller, Götschi, Andrea, Seraphina Kissling, Andrea Götschi, Ciurea, Adrian, Exer, Pascale, Bürki, Kristina, Möller, Burkhard, Adrian Ciurea, Alexander Bernatschek, Micheroli, Raphael, Michael J Nissen, Kissling, Seraphina, Pascale Exer, Nissen, Michael J, Kristina Bürki, Scherer, Almut, Raphael Micheroli, Almut Scherer   +19 more
core   +2 more sources

TaILOR: a randomised trial to compare the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to standard care pathways in people with inflammatory arthritis: a study protocol

Trials
Background Inflammatory arthritis comprises lifelong conditions, such as rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis that require long-term treatment and regular monitoring.
Gretchen Brewer, Victoria Harris, Christopher Mwema, Abhishek Abhishek, Ailsa Bosworth, Christine Bundy, Clare Clark, Elizabeth Conroy, Helen Dakin, Emma Dures, Joe Eddison, Anne Francis, James Galloway, Alice Jennings, Helen Lall, Elizabeth MacPhie, Sam Norton, Mark Perry, Jane Raleigh, Mel Brooke Turfrey, Laura Coates   +20 more
doaj   +1 more source

Sex‐Related Differences in Efficacy and Safety Outcomes in Axial Spondyloarthritis Randomized Clinical Trials: A Systematic Literature Review and Meta‐Analysis

Arthritis care & research
We aimed to assess differences in baseline characteristics, efficacy, and safety of advanced therapies between male and female patients with axial spondyloarthritis (axSpA) in randomized controlled trials (RCTs).
A. Gao, Jordi Pardo Pardo, S. Dang, L. Gensler, P. Mease, L. Eder   +5 more
semanticscholar   +1 more source

Axial Spondyloarthritis: An Evolving Concept [PDF]

, 2015
Axial spondyloarthritis (AxSpA) is the prototype of a family of inter-related yet heterogeneous diseases sharing common clinical and genetic manifestations: the spondyloarthritides (SpAs).
Nelly Ziadé
core  

Biopsychosocial factors should be considered when evaluating central sensitization in axial spondyloarthritis

Rheumatology International, 2023
To identify the determinants of central sensitization (CS) in patients with axial spondyloarthritis (axSpA). Central Sensitization Inventory (CSI) was used to determine CS frequency. Disease-related variables including Bath Ankylosing Spondylitis Disease
Aylin Sarıyıldız, İlke Coşkun Benlidayı, I. Turk, Serife Seyda Zengin Acemoglu, I. Unal   +4 more
semanticscholar   +1 more source

Short‐Term Response to Biologic Therapy in Psoriatic Arthritis Is Not Influenced by Disease Duration at Initiation of Therapy

Arthritis Care &Research, EarlyView.
Objective We aimed to determine whether the short‐term response to biologics in biologic‐naive psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. Methods Patients with PsA who started on biologic therapy from the year 2000 to 2025 were included for analysis.
Sung Min Cho, Shangyi Gao, Daniel Pereira, Richard J. Cook, Dafna D. Gladman   +4 more
wiley   +1 more source

Clinical characteristics of non-radiographic axial spondyloarthritis: Results of the Korean Nonradiographic Axial SPondyloArthritis (KONASPA) data

, 2021
Aim: To evaluate clinical characteristics and natural history of non-radiographic axial spondyloarthritis (nr-axSpA) using KOrean Nonradiographic Axial SPondyloArthritis (KONASPA) data. Methods: Data were collected from 11 centers in South Korea.
김태종, 신기철, 오지선, 차훈석, 김용길, 백한주, 이연아, 이은영, 서미령, 김태환, 박민찬, 정혜민, 이상훈   +12 more
core   +1 more source

Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS)

Rheumatology and Therapy
Introduction To assess differences in the diagnosis journey and access to care in a large sample of patients with axial spondyloarthritis (axSpA) from around the world, included in the International Map of Axial Spondyloarthritis (IMAS). Methods IMAS was
Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, Christine Bundy, Souzi Makri, José Correa-Fernández, Shashank Akerkar, Jo Lowe, Elie Karam, Victoria Navarro-Compán   +9 more
doaj   +1 more source

Features of the course and outcomes of COVID-19 in patients with axial spondyloarthritis

Научно-практическая ревматология, 2022
The 2019 coronavirus disease pandemic (COVID-19) is particularly challenging not only for doctors, but also for patients with inflammatory diseases, including spondyloarthritis. Although a large number of studies have been conducted over the past 2 years
Sh. F. Erdes
doaj   +1 more source

Diagnosis, monitoring, and management of axial spondyloarthritis

Rheumatology International
Axial spondyloarthritis (axSpA) is a chronic condition predominantly affecting the spine and sacroiliac joints. This article provides an in-depth overview of the current approaches to diagnosing, monitoring, and managing axSpA, including insights into ...
O. Zimba, B. Koçyiğit, Mariusz Korkosz
semanticscholar   +1 more source